These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25473809)

  • 21. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
    Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
    Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NCI Alliance for Nanotechnology in Cancer - from academic research to clinical interventions.
    Grodzinski P; Liu CH; Hartshorn CM; Morris SA; Russell LM
    Biomed Microdevices; 2019 Mar; 21(2):32. PubMed ID: 30904965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biofunctionalized silver nanoparticles: advances and prospects.
    Ravindran A; Chandran P; Khan SS
    Colloids Surf B Biointerfaces; 2013 May; 105():342-52. PubMed ID: 23411404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conference scene: 2nd annual European conference for clinical nanomedicine.
    Löffler B
    Nanomedicine (Lond); 2009 Oct; 4(7):705-8. PubMed ID: 19839806
    [No Abstract]   [Full Text] [Related]  

  • 25. Current issues in medically assisted reproduction and genetics in Europe: research, clinical practice, ethics, legal issues and policy.
    Harper J; Geraedts J; Borry P; Cornel MC; Dondorp WJ; Gianaroli L; Harton G; Milachich T; Kääriäinen H; Liebaers I; Morris M; Sequeiros J; Sermon K; Shenfield F; Skirton H; Soini S; Spits C; Veiga A; Vermeesch JR; Viville S; de Wert G; Macek M;
    Hum Reprod; 2014 Aug; 29(8):1603-9. PubMed ID: 25006203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.
    Ilinskaya AN; Dobrovolskaia MA
    Nanomedicine (Lond); 2013 May; 8(5):773-84. PubMed ID: 23656264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toward the emergence of nanoneurosurgery: part II--nanomedicine: diagnostics and imaging at the nanoscale level.
    Leary SP; Liu CY; Apuzzo ML
    Neurosurgery; 2006 May; 58(5):805-23; discussion 805-23. PubMed ID: 16639314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles.
    Lanza GM; Winter PM; Caruthers SD; Hughes MS; Cyrus T; Marsh JN; Neubauer AM; Partlow KC; Wickline SA
    Nanomedicine (Lond); 2006 Oct; 1(3):321-9. PubMed ID: 17716162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging applications of nanomedicine in dermatology.
    Saraceno R; Chiricozzi A; Gabellini M; Chimenti S
    Skin Res Technol; 2013 Feb; 19(1):e13-9. PubMed ID: 22175818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantum dots and nanocomposites.
    Mansur HS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(2):113-29. PubMed ID: 20104596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer nanotechnology: application of nanotechnology in cancer therapy.
    Misra R; Acharya S; Sahoo SK
    Drug Discov Today; 2010 Oct; 15(19-20):842-50. PubMed ID: 20727417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of nanotechnology in developing new therapies for diseases of the nervous system.
    Jain KK
    Nanomedicine (Lond); 2006 Jun; 1(1):9-12. PubMed ID: 17716203
    [No Abstract]   [Full Text] [Related]  

  • 33. [Nanotechnologies: from information sciences to pharmacology].
    Grognet JM
    Therapie; 2008; 63(1):1-9. PubMed ID: 18387270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxicity of novel nanosized formulations used in medicine.
    El-Ansary A; Al-Daihan S; Bacha AB; Kotb M
    Methods Mol Biol; 2013; 1028():47-74. PubMed ID: 23740113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feature issue introduction: quantum dots for photonic applications.
    Lee KS; Prasad PN; Huyet G; Tan CH
    Opt Express; 2012 May; 20(10):10721-3. PubMed ID: 22565697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dye-doped silica nanoparticles as luminescent organized systems for nanomedicine.
    Montalti M; Prodi L; Rampazzo E; Zaccheroni N
    Chem Soc Rev; 2014 Jun; 43(12):4243-68. PubMed ID: 24643354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanosize, mega-impact, potential for medical applications of nanotechnology.
    Ashammakhi N
    J Craniofac Surg; 2006 Jan; 17(1):3-7. PubMed ID: 16432397
    [No Abstract]   [Full Text] [Related]  

  • 38. Multifunctional nanoparticles--properties and prospects for their use in human medicine.
    Sanvicens N; Marco MP
    Trends Biotechnol; 2008 Aug; 26(8):425-33. PubMed ID: 18514941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From diagnostics to therapy: prospects of quantum dots.
    Azzazy HM; Mansour MM; Kazmierczak SC
    Clin Biochem; 2007 Sep; 40(13-14):917-27. PubMed ID: 17689518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanotechnology controlled drug delivery for treating bone diseases.
    Yang L; Webster TJ
    Expert Opin Drug Deliv; 2009 Aug; 6(8):851-64. PubMed ID: 19637973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.